Immediate Impact

59 standout
Sub-graph 1 of 20

Citing Papers

Biomedical SERS – the current state and future trends
2024 Standout
New immune cell engagers for cancer immunotherapy
2024 Standout
2 intermediate papers

Works of C. Klinkenstein being referenced

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study
2007

Author Peers

Author Last Decade Papers Cites
C. Klinkenstein 256 339 16 173 2 381
Ursula Haak 278 408 19 225 4 443
Sabine Neser 279 379 18 195 6 428
Baha Alkuzweny 253 363 23 178 7 450
Tanja Rixecker 230 309 12 149 5 416
KM Ardeshna 255 330 15 137 3 368
Steven Corso 216 286 18 164 9 417
RM Braziel 221 331 21 157 5 432
JG Gribben 227 285 19 160 6 428
Marc Heizmann 138 269 21 155 9 354
T Beck 159 261 18 146 5 382

All Works

Loading papers...

Rankless by CCL
2026